AVENUE THERAPEUTICS INC - COM NEW (ATXI)

CUSIP: 05360L205

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM NEW
Total 13F shares
1,835,397
Share change
-218,492
Total reported value
$11,140,868
Price per share
$6.07
Number of holders
32
Value change
-$1,317,927
Number of buys
14
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 05360L205?
CUSIP 05360L205 identifies ATXI - AVENUE THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVENUE THERAPEUTICS INC - COM NEW (ATXI) as of Q1 2021

As of 31 Mar 2021, AVENUE THERAPEUTICS INC - COM NEW (ATXI) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,835,397 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., National Asset Management, Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Nuveen Asset Management, LLC, Nantahala Capital Management, LLC, Parametric Portfolio Associates LLC, and JPMORGAN CHASE & CO. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.